Cancer detections and its fastest Treatments

Image

The Editorial Board of Journal of Cancer Clinical Trials is overwhelmed by the response and eagerness of the academic and research contributors to publish with the journal and take part in the year-long celebrations. During this year we look forward to taking some initiatives that would encourage and reward our prospective audience which include  research scientists, decision-makers and a range of professionals in the IT community.

Journal of Cancer Clinical Trials an open access, peer-reviewed journal that focuses on all aspects of Application Programming, Business Applications, Network Programming, System Administration, Web Systems, Data Structures and Algorithms, Operating Systems and beyond. Celebrating a successful publication history, Journal reiterates its commitment to promote systematic enquiry and explorations in various fields Brain Cancer Clinical Trials, Cancer Clinical Trials , Skin Cancer Clinical Trials etc.

 Prospective academicians and scientists are encouraged to utilize this opportunity to get their articles reviewed, processed and published at relatively faster pace and at lower charges. The journal invites different types of articles including original research article, review articles, short note communications, case reports, Editorials, letters to the Editors and expert opinions & commentaries from different regions for publication.

A standard editorial tracking system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing. Manuscripts can be uploaded online at Editorial Tracking System (https://www.scholarscentral.org/submissions/cancer-clinical-trials.html)or forwarded to the Editorial Office or  cancer@eclinicalsci.com

 

How we work:

  • After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
  • A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
  • Author proof is generated within 7 working days after the acceptance decision.

Benefits on Publication:

Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.

Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.

Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.

Color Art: In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.

Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.

Media Contact:


Rebecca J
Assistant Editorial Manager
Journal of Cancer Clinical Trials
Whatsapp No:  +1-504-608-2390

Email:  cancer@eclinicalsci.com